arrow
S

Silvia Ferrero

University of Barcelona
H指数:9
被引数:975

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Noninvasive prediction models of intra-amniotic infection in women with preterm labor” published in the “Am J Obstet Gynecol 2023 Jan;228(1):78.e1-78.e13

勘误:发表于《Am J Obstet Gynecol 2023 Jan;228(1):78.e1-78.e13》的“非侵入性预测模型对有早产症状的妇女发生羊膜腔内感染的预测”

2025-07-090
PRE
Preterm prelabor rupture of membranes: the use of amniocentesis to detect intraamniotic infection reduces maternal and neonatal duration of antibiotic exposure

早产临产前胎膜破裂:采用羊膜腔穿刺术检测羊膜腔内感染,可缩短母体和新生儿的抗生素暴露时间。

2025-06-100
PRE
Intra-amniotic infection and/or inflammation is associated with fetal cardiac concentric hypertrophy and diastolic dysfunction in preterm labor and preterm prelabor rupture of membranes

羊膜腔内感染和/或炎症与早产和早产胎膜早破中胎儿心脏向心性肥大和舒张功能障碍有关

2024-06-010
PRE
Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes

个体化治疗未足月胎膜早破延长潜伏期,降低早产率,改善新生儿结局

2022-08-0121
PRE
Development and validation of a multivariable prediction model of spontaneous preterm delivery and microbial invasion of the amniotic cavity in women with preterm labor

早产妇女自发性早产和微生物侵入羊膜腔的多变量预测模型的建立和验证

2020-09-0129
OAAI
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗CD30-positive外周T细胞淋巴瘤 (ECHELON-2): 一项全球性、双盲、随机、3期临床试验

LANCET
IF88.5
2019-01-01535
OAAI